Sorrento Therapeutics

$10.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.45 (-4.45%) Today

+$0.38 (+3.93%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell SRNE and other stocks, options, and ETFs commission-free!

About SRNE

Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. Ji in 2006 and is headquartered in San Diego, CA. The listed name for SRNE is Sorrento Therapeutics, Inc. Common Stock.

CEO

Henry H. Ji

Employees

502

Headquarters

San Diego, California

Founded

2006

Market Cap

2.95B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

13.49M

High Today

$10.36

Low Today

$9.40

Open Price

$10.09

Volume

15.16M

52 Week High

$19.39

52 Week Low

$1.55

SRNE Earnings

-$0.50

-$0.33

-$0.17

$0.00

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

— per share

Actual

-$0.25 per share